CAMELLIA Cohort: A Longitudinal Study to Understand Sexual Health and Prevention Among Women in Alabama

Sex: All

Ages: 18 Years – 89 Years

Healthy volunteers: No

Phase: NA

Enrollment: 830

Sponsor: University of Alabama at Birmingham

Summary

Pre-exposure prophylaxis (PrEP) is an important biomedical human immunodeficiency virus (HIV) prevention tool and may particularly benefit black, cis and trans-gender women, who are at an increased risk for HIV and Sexually Transmitted Infections (STIs). The purpose of this study is to use a population-based approach to create a cohort of cis and trans-gender women at risk for future HIV acquisition to better understand the factors associated with the risk of STIs and HIV diagnosis and predictors of PrEP use.

Eligibility Criteria

Inclusion Criteria: * Self identify as a Cis-gender or Trans-gender woman * Age 18 - 89 * Reported STI in past 3 months by the Alabama Department of Public Health (ADPH) * Gonorrhea and Syphilis negative * HIV negative at screening encounter * Live in Alabama * Have access to a private smart phone Exclusion Criteria: * Live outside of Alabama * Positive diagnosis for HIV, Gonorrhea, or Syphilis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05463692). StuddyBuddy aggregates publicly available trial information.